Role of CD137/4-1BB and its ligand in the NK cell mediated immune surveillance of acute myeloid leukemia.

被引：0
|
作者：
Baessler, Tina [1 ]
Krusch, Matthias [1 ]
Baltz, Katrin M. [1 ]
Schmiedel, Benjamin J. [1 ]
Schmetzer, Helga M. [2 ]
Kanz, Lothar [1 ]
Salih, Helmut R. [1 ]
机构：
[1] Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany
[2] Univ Munich, Dept Med 3, Munich, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.880.880
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
880
引用
收藏
页码：269A / 269A
页数：1
相关论文
共 50 条
  • [1] Immune responses in 4-1BB (CD137)-deficient mice
    Kwon, BS
    Hurtado, JC
    Lee, ZH
    Kwack, KB
    Seo, SK
    Choi, BK
    Koller, BH
    Wolisi, G
    Broxmeyer, HE
    Vinay, DS
    JOURNAL OF IMMUNOLOGY, 2002, 168 (11): : 5483 - 5490
  • [2] Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival
    Cho, HR
    Kwon, B
    Yagita, H
    La, S
    Lee, EA
    Kim, JE
    Akiba, H
    Kim, J
    Suh, JH
    Vinay, DS
    Ju, SA
    Kim, BS
    Mittler, RS
    Okumura, K
    Kwon, BS
    TRANSPLANT INTERNATIONAL, 2004, 17 (07) : 351 - 361
  • [3] 4-1BB (CD137) in anticancer chimeras
    Melero, Ignacio
    Berraondo, Pedro
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (12):
  • [4] Expression of 4-1BB(CD137) and its ligand 4-1BBL in human atherosclerosis
    Ghaderi, M
    Wågsäter, D
    Olofsson, P
    Sheikine, Y
    Sirsjö, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 6 - 6
  • [5] The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
    Lynch, David H.
    IMMUNOLOGICAL REVIEWS, 2008, 222 : 277 - 286
  • [6] Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells
    Salih, HR
    Kosowski, SG
    Haluska, VF
    Starling, GC
    Loo, DT
    Lee, F
    Aruffo, AA
    Trail, PA
    Kiener, PA
    JOURNAL OF IMMUNOLOGY, 2000, 165 (05): : 2903 - 2910
  • [7] Role of CD137 (4-1BB) in the SCID T cell transfer colitis model
    Maerten, P
    Shen, C
    Cadot, P
    Van Assche, G
    Geboes, K
    Kwon, B
    Rutgeerts, P
    Ceuppens, J
    GASTROENTEROLOGY, 2003, 124 (04) : A333 - A333
  • [8] The therapeutic potential of 4-1BB (CD137) in cancer
    Nam, KO
    Kang, WJ
    Kwon, BS
    Kim, SJ
    Lee, HW
    CURRENT CANCER DRUG TARGETS, 2005, 5 (05) : 357 - 363
  • [9] The promise of 4-1BB (CD137) mediated immunomodulation and immunotherapy for viral diseases
    Rahman, Md Masudur
    Badruzzaman, A. T. M.
    Hossain, Ferdaus Mohd Altaf
    Husna, Asmaul
    Bari, Abusaleh Mahfuzul
    Eo, Seong Kug
    FUTURE VIROLOGY, 2017, 12 (07) : 361 - 372
  • [10] The Activation Marker CD137 (4-1BB) Identifies a Highly Active Subset of Donor Lymphocytes Against Acute Myeloid Leukemia
    Abdelhakim, Haitham
    Li, Meizhang
    Braun, Mitchell
    Godwin, Andrew
    Dunavin, Neil
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
12345